Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-02-19

FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (ANDA 078707). This action represents an approval related to the generi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)